tiprankstipranks
Trending News
More News >
Altamira Therapeutics Ltd. (CYTOF)
:CYTOF
US Market

Altamira Therapeutics (CYTOF) Revenue

Compare
599 Followers

Altamira Therapeutics Revenue

Altamira Therapeutics had a revenue of 52.73K in the quarter ending Jun 30, 2023, with 0.00%. This bring the company's revenue in the last twelve months to -353.22K, Increased -35.56%. In the fiscal year ending Dec 31, 2023, Altamira Therapeutics had annual revenue of 0.00 with -100.00% growth.
Revenue (ttm)
-353.22K
Revenue Growth
P/S Ratio
Infinity
Revenue/Employee
$0
Employees
12
Market Cap
$570.40K

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2023
0.00-305.62K-100.00%
Dec 31, 2022
305.62K241.73K+378.41%
Dec 31, 2021
63.88K-110.59K-63.39%
Dec 31, 2020
174.47K230.47K-411.56%
Dec 31, 2019
-56.00K-1.32M-104.42%
Dec 31, 2018
1.27M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis